baber/WOPTO huggingface dataset:
Patent PL-1931554-T3 (PL)
Title: Method of driving plurality of mine vehicles in mine, and transport system
Inventor: HEINO TIMO
IPC: B62D1/28
Filed: 2006-10-02
Abstract: A method of driving mine vehicles in a mine, and a transport system. A plurality of mine vehicles is arranged in succession and driven in convoy between working areas. A master vehicle in the convoy is driven manually, and slave vehicles follow the master, provided with no mechanical connection. In the working areas, the convoy is disassembled, since single vehicles are each driven separately. When assigned tasks in the working areas have been completed, the vehicles are reassembled into a convoy so as to be driven to a next working area.
Patent PL-2077799-T3 (PL)
Title: Speech valve
Inventor: FAGAN MICHAEL J
IPC: A61F2/20
Filed: 2007-10-18
Abstract: A speech valve (10) has a body (12, 14,16) and a projection (82). The body (12, 14, 16) is at least partially insertable into a fistula between the trachea and the oesophagus so as to provide a closable passage between the trachea and the oesophagus with the projection (82) lying outside the fistula to resist passage of the valve (10) through the fistula. The body (12, 14, 16) has a seat (30) and the valve includes a closure member (62) which is movable between an open position and a closed position in which the closure member (62) contacts the seat (30) so as to close the valve (10) and thereby close the passage between the trachea and the oesophagus. The body (12, 14, 16) and the closure member (62) have respective guidance surfaces (58, 66) which slidingly contact one another to guide the closure member (62) between the open and the closed positions so that the sliding contact tends to clean the guidance surfaces (58, 66).  The body (12, 14, 16) and the closure member (62), or at least their respective closure surfaces (58, 66) are made of a ceramic material.  In one preferred embodiment, the closure member (62) is biased towards the closed position by a repulsive magnetic force.  In another preferred embodiment, the closure member (62) rotates relative to the body as it moves axially between the open and closed positions.
Patent PL-2227240-T3 (PL)
Title: Parvovirus cancer therapy and combination with chemotherapy
Inventor: ROMMELAERE JEAN
IPC: A61K31/7068
Filed: 2008-12-23
Abstract: Described is a pharmaceutical composition containing (a) a parvovirus and (b) a chemotherapeutic agent, preferably as separate entities. The parvovirus might be based on parvovirus H1, LuIII, Mouse minute virus (MMV), Mouse parvovirus (MPV), Rat minute virus (RMV), Rat parvovirus (RPV), Rat virus (RV), vectors based on the foregoing viral species, and/or cells capable of actively producing the foregoing viral species. The pharmaceutical composition is beneficial for the treatment of pancreatic cancer.
Patent PL-2131090-T3 (PL)
Title: Safety quick coupling for pipes
Inventor: ALDINIO COLBACHINI GIUSEPPE
IPC: F16L37/14
Filed: 2009-06-05
Abstract: A safety quick coupling for pipes in general comprises a cable (4) adapted for engagement in a space defined between facing slots (8, 9) respectively of the end portions (7, 10) of the male part (3) and female part (2) of the coupling, the mechanical engagement of said cable (4) in the seat therefor, even in the presence of impacts, vibrations, torques and the like on the coupling (1) being assured by the engagement of a loop element (5), provided on the free end portion of the cable (4) projecting outside of the coupling (1), in a spring catch connection element (6) mounted on the outer wall of the end portion (10) of said female part (2).  With respect to prior quick couplings, the inventive coupling provides the advantage of assuring a tight mechanical connection even in the presence of vibrations, impacts, torques and the like loading the coupling.
Patent PL-2145745-T3 (PL)
Title: A method of forming a brush seal
Inventor: BOWSHER AARON
IPC: F16J15/32
Filed: 2009-07-10
Abstract: This invention relates to a method of forming brush seals and to brush seals themselves. Thus a back plate 10, which defines an anchor recess 11, a reservoir recess 12 and a land 13 is laid horizontally. A bristle pack 14 is then laid on top of the back plate 10, so that one end 15 overlies a recess 11 and the other, 16, projects beyond the land 13. The bristles are then clamped in position by clamp 21 and epoxy resin is poured into the recess 11 as indicated by the arrows. A mould is introduced over the recess. Once the resin is cured, the mould can be removed and it will be noted that excess epoxy resin has fallen into the recess 12 preventing resin wicking beyond the land 13 and interfering with the performance of the bristles.
Patent PL-2229956-T3 (PL)
Title: Multimeric constructs
Inventor: SCARIA ABRAHAM
IPC: C07H21/04
Filed: 2005-09-13
Abstract: Multimeric fusion proteins of an Ig-like domain of Flt-1 are rendered functional by inclusion or a linker moiety. Vectors encoding the fusion proteins and host cells expressing the fusion proteins can be used therapeutically to block neovascularization in individuals with pathological conditions related to neovascularization. Such conditions include age-related macular degeneration, cancer, psoriasis, proliferative diabetic retinopathy, asthma, uveitis, osteoarthritis, and rheumatoid arthritis. The same means of multimerization used for an lg-like domain of Flt-1,  i . e ., a linker and a multimerization domain, can be used for other polypeptides, including extracellular receptors, antibody variable regions, cytokines, chemokines, and growth factors.
Patent PL-2377536-T3 (PL)
Title: Methods of Using Sustained Release Aminopyridine Compositions
Inventor: BLIGHT ANDREW R
IPC: A61K31/44
Filed: 2005-04-11
Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and the use of the composition to treat various neurological diseases, including multiple sclerosis. A method of selecting individuals based on responsiveness to a treatment, including, for example, identifying individuals who responded to treatment with a sustained release fampridine composition.
Patent GR-3000534-T3 (GR)
Title: Aqueous alcaline injectable solution of torasemid ready for use and process for preparation thereof
Inventor: DEMMER FRITZ DR RER NAT
IPC: A61K31/64
Filed: 1990-06-07
Abstract: The present invention provides an aqueous, alkaline injection solution of torasemide ready for injection, which contains a physiologically compatible alkaline buffer with a pH value of from 9.3 to 9.9 and with a buffer capacity of up to 0.1 val/liter together with an organic solvent in an amount of from 5 to 20% by weight selected from the group of polyethylene glycols with a molecular weight of from 100 to 1500, polypropylene glycols with a molecular weight of from 50 to 1000, glycerol, propylene glycol, ethanol and propanol, the torasemide being present in a concentration of from 2 to 40 mg/ml. Torasemide solutions are useful to inhibit inflammation or promote diuresis. The present invention also provides a process for the preparation of this solution, wherein torasemide is suspended in the above organic solvent brought into solution by the addition of aqueous alkali, adding the buffer and other adjuvants and adjusting the PH value to 9.3 to 9.9.
Patent GR-3002463-T3 (GR)
Title: Valve cup for aerosol container
Inventor: KIMBALL JAMES F
IPC: B65D83/14
Filed: 1991-08-12
Abstract: A valve cup (18) for use in an aerosol dispenser is configured to provide an anti-seating feature. In one embodiment, dimples are impressed in the sidewalls (30) of a valve cup to inhibit seating of the valve cup flange on the circular shaped ring around the periphery of an opening at one end of the aerosol dispenser. In a second embodiment, detents (40) are placed on the edge of the flange in which the sidewalls (34) of the valve cup terminate to inhibit the seating of the flange on the circular shaped ring.
Patent GR-3003055-T3 (GR)
Title: A laminar structure for administering a chemical at a controlled release rate
Inventor: KIM KWON H
IPC: A61L15/16
Filed: 1991-11-01
Abstract: A laminar structure for administering a chemical at a controlled release rate is disclosed. The structure comprises a backing member which acts as a boundary through which the chemical does not pass. Contacting at least a portion of the backing member is a chemical containing layer having therein a first chemical portion and a second chemical portion. The first and second chemical portions comprise a mixture of chemical in a first concentration transport mode and a second concentration transport mode. The mixture being in a ratio to give a desired chemical release rate from the chemical containing layer.
Patent GR-3005671-T3 (GR)
IPC: C07D521/00
Filed: 1992-09-10
Abstract: Trifluoromethylphenylazolylmethyloxiranes of the general formula I <IMAGE>  in which R<1> represents hydrogen, halogen, nitro, phenyl, phenoxy, alkyl, alkoxy, haloalkyl or haloalkoxy, and, moreover, R<1> together with the phenyl ring can also form a naphthyl radical which is unsubstituted or substituted,  n represents an integer from 1 to 5,  R<2> represents ortho- or para-trifluoromethyl,  X represents CH or N, and their acid addition salts and metal salts which are tolerated by plants, and fungicides containing these compounds.
Patent GR-3014931-T3 (GR)
Title: Immunomodulatory azaspiranes.
Inventor: BADGER ALISON MARY
IPC: C07D/
Filed: 1995-02-01
Abstract: The invention relates to pharmaceutical compositions containing immunomodulatory azaspiranes of the formulae (I) and (II): <CHEM> wherein n is 3-7, m is 1 or 2, and R<1> to R<6> are hydrogen or alkyl. Also disclosed are novel azaspiranes and processes for their preparation.
Patent GR-3015196-T3 (GR)
Title: Process for environmentally safe disposal of noxious solid, liquidand/or gaseous substances at temperatures of 400 to 1800 degrees celsius.
Inventor: STRAUCH GERHARD
IPC: C04B18/04
Filed: 1995-02-27
Abstract: The process permits : 1) rational use of solid, liquid and gaesous waste  materials, special waste materials and poisons for residue-free production of environmentally safe ceramic products for various practical applications (for example building materials and industrial containers) at temperatures of 400 to 1800 degrees; 2) in special cases, conversion of extremely toxic substances to less harmful solids which can be deposited on refuse dumps; 3) direct, residue-free processing of hot slags, ashes and the like to form building elements; 4) purification of gases, in particular flue gases, at elevated temperatures of 400 to 1800 degrees using ceramic earths, the solid end product of which is suitable for a wide range of applications; 5) use of compressed flue gases to spray liquids, dust and/or granules into the chimney.
Patent GR-3015902-T3 (GR)
Title: Process for separating terpenes from essential oils.
Inventor: CULLY JAN DR
IPC: C11B9/02
Filed: 1995-04-20
Abstract: A process for removing terpenes from essential oils is described and entails
 a) the terpene-containing essential oils being contacted with a polar solid (adsorbent),
 b) the loaded adsorbent being separated from the liquid phase enriched in terpenes, and
 c) the adsorbent loaded with essential oil being extracted with condensed CO2. 
<??>It is possible in this way substantially to remove the terpenes and, at the same time, to obtain the essential oils in high yield and good quality.
Patent GR-3020751-T3 (GR)
Title: New 16-alpha steroid-methylation process.
Inventor: ROUSSEL PATRICK
IPC: C07J5/00
Filed: 1996-08-08
Abstract: The invention relates to a new process for the preparation of the compounds of formula (I): <IMAGE> in which the A and B rings represent a 3-keto  DELTA 4 6-R3 residue, optionally in protected form at 3, or a 3-keto  DELTA 1,4 6-R3 residue, R is methyl or -CH2OR' where R' is hydrogen or an ether or ester residue, R1 and R2 form a  beta  epoxide or a second bond, or R1 is hydrogen, ketone or  alpha  or  beta  hydroxyl, optionally in etherified or esterified form, and R2 is hydrogen, or R1 is hydrogen and R2 is  alpha -hydroxy, or R1 is an optionally etherified or esterified  beta -hydroxy and R2 is an  alpha  fluorine or bromine, R3 is hydrogen or an  alpha  or  beta  fluorine or methyl, according to which a  DELTA 16(17) derivative is treated with a methylating agent, followed by hydrolysis of the 16 alpha -methylated enolate and oxidation of the enol obtained. The compounds (I) are known anti-inflammatory agents or possible precursors.
Patent GR-3020081-T3 (GR)
Title: Process for preparing ultrasonically sealed transdermal drug delivery systems
Inventor: RUDELLA MICHAEL D
IPC: A61K9/70
Filed: 1996-05-30
Abstract: The invention relates to a process of sealing transdermal drug delivery system components together which comprises contacting the surfaces of the components to be sealed together with each other and exposing the contacted surfaces to ultrasonic radiation while said surfaces are still in contact to produce a seal of said surfaces in a predetermined manner.
Patent GR-3020562-T3 (GR)
Title: Improvements relating to dredgers
Inventor: BURRING PAUL JOHN
IPC: E02F5/10
Filed: 1996-07-17
Abstract: A method and apparatus for dredging in flowing waters comprising a support member (3) carrying thrust means (13) so that the thrust means (13) is directed downwardly towards the area to be cleared, the support member (3) being mounted in the water so that in operation it presents a surface towards the flow of water which causes a resultant downward component of force to balance the upward component of force caused by the thrust means (13).
Patent GR-3021196-T3 (GR)
Title: Novel derivatives of N-benzoylproline, process for their preparation and drugs containing them
Inventor: RAULT SYLVAIN
IPC: C07D207/24
Filed: 1996-09-30
Abstract: Compounds of general formula (I): <IMAGE>  where A, R1, R2, R3, R4, R5 and R6 are defined in the description. Medicaments.
Patent GR-3024350-T3 (GR)
Title: Method for producing human nerve growth factor-2
Inventor: IWANE MAKOTO
IPC: C12N1/21
Filed: 1997-08-01
Abstract: A transformant, which horbors a recombinant vector containing a DNA which codes for human nerve growth factor 2 and a DNA which codes for the pro-region of a nerve growth factor at 5'-terminal of said DNA, produces human nerve factor 2 in stable and large amount in a culture medium.
Patent GR-3025124-T3 (GR)
Title: An artificial vagina.
Inventor: GAUNTLETT ARTHUR EDWARD
IPC: A61H19/00
Filed: 1997-10-22
Abstract: PCT No. PCT/GB93/02118 Sec. 371 Date Jun. 13, 1994 Sec. 102(e) Date Jun. 13, 1994 PCT Filed Oct. 13, 1993 PCT Pub. No. WO94/08547 PCT Pub. Date Apr. 28, 1994.An artificial vagina is described includes a sheath (1) made from a flexible waterproof material. The sheath tapers from one end to the other, the wider end having a resealable opening (2) closed by a screw-threaded stopper (3). Projecting from the inner end of stopper (3) is an eye loop (4) connected to a hook (5) which swivels on wire loop (6) secured to tab (7). The tapered end of sheath (1) has a soft flexible undulating wall (8) and a bulbous portion (9) from which extends an annular membrane (10), the peripheral edge of which has a reinforced elastic rib (11). When assembled with the hook (5) connected to wire loop (6) a fluid chamber (12) is formed and filled with warm water (13) forming a chamber (14). Aperture (15) is formed in wall (8) to connect with bulbous portion (9) for the passage of the water (13).
Patent GR-3031777-T3 (GR)
Title: Process for producing pasty washing agents.
Inventor: BEAUJEAN HANS-JOSEF
IPC: C11D17/00
Filed: 1999-11-08
Abstract: A process for producing a paste-form, substantially water-free detergent by heating a mixture of nonionic and anionic surfactants to a predetermined temperature, adding soap in particulate form to the heated mixture, then cooling the mixture, and adding builder components and a bleaching agent to the mixture.
Patent GR-3031811-T3 (GR)
Title: Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
Inventor: VAN DER BRUGGEN PIERRE
IPC: C12N5/09
Filed: 1999-11-10
Abstract: Tumor rejection antigens derived from tumor rejection precursor MAGE-3 have been identified. These "TRAS" bind to the MHC-class I molecule HLA-A2, and the resulting complexes stimulate the production of cytolytic T cell clones which lyse the presenting cells. The peptides and complexes may be used diagnostically, therapeutically, and as immunogens for the production of antibodies, or as targets for the generation of cytolytic T cell clones.
Patent GR-3033831-T3 (GR)
Title: Surface modification of polymers and carbon-based materials
Inventor: GUDIMENKO YURI
IPC: C08J7/054
Filed: 2000-06-30
Abstract: A process for surface modification of polymers and carbon-based materials, and materials produced by the process. The preferred surface modification process of the present invention comprises three steps: a first activation step wherein reactive hydrogen groups are formed in a surface layer of a polymeric or carbon-based material; a second silylation step wherein the reactive hydrogen groups are reacted with a silylating agent to form silicon-containing groups; and a third stabilization step wherein an upper portion of the activated, silylated layer is oxidatively converted to a silicon dioxide enriched surface layer. The process can be performed using materials not having pre-existing reactive hydrogen groups or precursor groups. Surface modified materials according to the present invention have improved properties, such as erosion resistance and oxygen and water barrier properties, and are potentially useful in numerous industries, such as aerospace and packaging. <IMAGE>
Patent GR-3033984-T3 (GR)
Title: A dispensing device for detergent tablet
Inventor: LEMAIRE LIESBETH JOHANNA CAROL
IPC: A47L15/44
Filed: 2000-07-19
Abstract: The present invention provides a dispensing device (10) for detergent tablets comprising a securing means (30). Said securing means avoids that said dispensing device may be dropped off from the cutlery or crockery basket during the wash cycle in an automatic dish washing machine. Said securing means is a clip (32) which secures into any of the perforations of a cutlery basket.
Patent GR-3034282-T3 (GR)
Title: Inhalator designed to provide multiple doses of a dry pharmacological powder
Inventor: KELLER MANFRED
IPC: A61M15/06
Filed: 2000-08-30
Abstract: The inhaler has a casing (100,150) with a fitted special mouthpiece (900), shrouded by a removable protective cap (950). The casing holds a slide valve guide rail (200), a metering slide valve (300), a closure, a slide, a funnel, counter (700), valve cover (800) and valve guide (850). When the protective cover (950) is removed, the powder for inhalation is metered in a trip action, and a dose is contained within the dose cavity to be carried by the metering slide valve (300) to the mouthpiece (900). The closure is only displaced by the valve cover (800) by a min. inhalation intensity, for the powder dose to be released for inhalation. If the inhaler is used with an electronic module, and a controlled nozzle, the relevant inhalation data can be determined for controlled flow conditions.
Patent GR-3034744-T3 (GR)
Title: 3-substituted 1-arylindole compounds
Inventor: ANDERSEN KIM
IPC: A61K31/445
Filed: 2000-11-02
Abstract: 3-substituted 1-arylindole compound having general Formula I <CHEM>       wherein Ar is an optionally substituted aryl group; X represents a bond, a divalent hydrocarbon group or methyleneoxy or -thioxo; R<1>_R<4> are hydrogen or substituents; R<5> is hydrogen, hydroxy, alkoxy, halogen, trifluoromethyl, alkyl or alkenyl; R<6> and R<7> are hydrogen, alkyl or alkenyl;   R<8> is alkyl or alkenyl a group of Formula 1a or 1b : <CHEM>   wherein; W is O or S; U is N or CH ; Z is (CH2)m, 1,2-phenylene, CH=CH, COCH2 or CSCH2-; V is O, S, CH2, or NR<10>, wherein R<10> is hydrogen or alkyl; U<1> is O, S, CH2 or NR<11>, wherein R<11> is as R<10>; and V<1> is NR<12>R<13>, OR<14>, SR<15> or CR<16>R<17>R<18>, where each of R<12>-R<18> are as the R<10>-substituents; R<9> is hydrogen or alkyl; or R<9> is linked to R<7> to form a ring; or R<8> and R<9> together form a morpholinyl or piperidinyl ring, the latter optionally substituted by alkyl or a group of Formula 1a or 1b, or a carbamoyl group, show central antiserotonergic activity and possibly also antidopaminergic activity and are, accordingly, useful in the treatment of central nervous system (CNS) disorders. The compounds are prepared by methodt known pr. se.
Patent GR-3036238-T3 (GR)
Title: Digital mobile telephone system in which each subscriber is assigned a telephone number and several subscriber identity module (sim) cards.
Inventor: HERMANSSON JAN
IPC: H04W8/18
Filed: 2001-07-18
Abstract: PCT No. PCT/SE93/00784 Sec. 371 Date Sep. 5, 1995 Sec. 102(e) Date Sep. 5, 1995 PCT Filed Sep. 30, 1993 PCT Pub. No. WO94/08433 PCT Pub. Date Apr. 14, 1994A digital mobile communication system comprises a switching center (MSC), a subscriber register (HLR) connected thereto, mobile terminals, such as mobile telephones, and subscriber-linked subscriber's cards, such as smart cards. Each subscription is allocated a subscriber's number and at least two subscriber's cards adapted to be activated so as to open a mobile terminal to incoming as well as outgoing traffic when inserted therein. When one of the subscriber's cards is activated, the other card or cards are necessarily deactivated so as to open a mobile terminal only to outgoing traffic when inserted therein. The subscriber register (HLR) is adapted to control the activation and the deactivation of the cards by the order of the subscriber.
Patent GR-3036479-T3 (GR)
Title: Transcutaneous in vivo activation of photosensitive agents in blood.
Inventor: RICHTER ANNA M
IPC: A61K31/365
Filed: 2001-08-30
Abstract: A method destroys or impairs target cells that have selectively accumulated a photosensitizing agent. The target cells are in the bloodstream of an intact animal, which bloodstream and animal further contain non-target cells. Radiation is applied transcutaneously to at least a portion of the intact animal at an intensity effective to impair or destroy selectively the target cells and to leave non-target cells relatively unimpaired. Target cells include leukemia cells, virus-containing cells, parasite-containing cells, and microorganisms such as bacteria, parasites and free viruses.
Patent DK-0645903-T4 (DK)
Inventor: DELPRAT MARC
IPC: H04W56/00
Filed: 1994-09-28
Granted: 2005-06-13
Abstract: The present invention relates to a filling burst structure used in a digital cellular radio communications system operating according to the principle of Time Division Multiple Access (TTMA), each cell of the system being associated with a beacon frequency subdivided into frames (T') which are repeated periodically and each comprising at least one signalling channel or beacon channel (ITO) for transmitting signalling messages (Bs) intended for mobile stations, the other channels (IT1, ..., IT7) being intended particularly for transmitting useful data (BT), the burst being sent on the channels of the beacon frequency which are not allocated to transmission of useful data or on certain time intervals of the signalling channel when there is no signalling data to be transmitted over these time intervals, characterised in that the filling burst (BRS) contains a signalling message. <IMAGE>
Patent TR-200400424-T4 (TR)
Title: IOP'nin kontrolü ve glokom tedavisi için 5HT2 agonistleri
Inventor: MAY JESSE A
IPC: C07D231/56
Filed: 2000-11-14
Abstract: 1-(2-aminopropil)-indazol -6-ol kullanilarak göz içi basincinin kontrolü ve glokom tedavisi için bilesimler ve yöntemler açiklanmistir.